FivepHusion announces the appointment of experienced industry executive to its board

David Ranson, executive chairman of FivepHusion, said, “As we pursue late clinical-stage development of our lead drug Deflexifol, augmenting and expanding the diversity and skill set of our Board is paramount to optimally positioning our company for global development activities and commercialisation." …